Photoactivatable Liposomes for Blue to Deep Red Light-Activated Surface Drug Release: Application to Controlled Delivery of the Antitumoral Drug Melphalan - Archive ouverte HAL
Article Dans Une Revue Bioconjugate Chemistry Année : 2023

Photoactivatable Liposomes for Blue to Deep Red Light-Activated Surface Drug Release: Application to Controlled Delivery of the Antitumoral Drug Melphalan

Résumé

Liposome-based nanoparticles able to release, via a photolytic reaction, a payload anchored at the surface of the phospholipid bilayer were prepared. The liposome formulation strategy uses an original drug-conjugated blue light-sensitive photoactivatable coumarinyl linker. This is based on an efficient blue light-sensitive photolabile protecting group modified by a lipid anchor, which enables its incorporation into liposomes, leading to blue to green light-sensitive nanoparticles. In addition, the formulated liposomes were doped with triplet–triplet annihilation upconverting organic chromophores (red to blue light) in order to prepare red light sensitive liposomes able to release a payload, by upconversion-assisted photolysis. Those light-activatable liposomes were used to demonstrate that direct blue or green light photolysis or red light TTA-UC-assisted drug photolysis can effectively photorelease a drug payload (Melphalan) and kill tumor cells in vitro after photoactivation.
Fichier principal
Vignette du fichier
islandora_165509.pdf (1.74 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04154766 , version 1 (06-07-2023)

Identifiants

Citer

Anaïs Brion, Juliane Chaud, Maxime Klimezak, Frédéric Bolze, Laura Ohlmann, et al.. Photoactivatable Liposomes for Blue to Deep Red Light-Activated Surface Drug Release: Application to Controlled Delivery of the Antitumoral Drug Melphalan. Bioconjugate Chemistry, 2023, 34 (7), pp.1304-1315. ⟨10.1021/acs.bioconjchem.3c00197⟩. ⟨hal-04154766⟩
24 Consultations
40 Téléchargements

Altmetric

Partager

More